Cargando…

Improved prediction of gestational hypertension by inclusion of placental growth factor and pregnancy associated plasma protein-a in a sample of Ghanaian women

BACKGROUND: We assessed whether adding the biomarkers Pregnancy Associated Plasma Protein-A (PAPP-A) and Placental Growth Factor (PlGF) to maternal clinical characteristics improved the prediction of a previously developed model for gestational hypertension in a cohort of Ghanaian pregnant women. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Antwi, Edward, Klipstein-Grobusch, Kerstin, Browne, Joyce L., Schielen, Peter C., Koram, Kwadwo A., Agyepong, Irene A., Grobbee, Diederick E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870183/
https://www.ncbi.nlm.nih.gov/pubmed/29587776
http://dx.doi.org/10.1186/s12978-018-0492-9
_version_ 1783309424747610112
author Antwi, Edward
Klipstein-Grobusch, Kerstin
Browne, Joyce L.
Schielen, Peter C.
Koram, Kwadwo A.
Agyepong, Irene A.
Grobbee, Diederick E.
author_facet Antwi, Edward
Klipstein-Grobusch, Kerstin
Browne, Joyce L.
Schielen, Peter C.
Koram, Kwadwo A.
Agyepong, Irene A.
Grobbee, Diederick E.
author_sort Antwi, Edward
collection PubMed
description BACKGROUND: We assessed whether adding the biomarkers Pregnancy Associated Plasma Protein-A (PAPP-A) and Placental Growth Factor (PlGF) to maternal clinical characteristics improved the prediction of a previously developed model for gestational hypertension in a cohort of Ghanaian pregnant women. METHODS: This study was nested in a prospective cohort of 1010 pregnant women attending antenatal clinics in two public hospitals in Accra, Ghana. Pregnant women who were normotensive, at a gestational age at recruitment of between 8 and 13 weeks and provided a blood sample for biomarker analysis were eligible for inclusion. From serum, biomarkers PAPP-A and PlGF concentrations were measured by the AutoDELFIA immunoassay method and multiple of the median (MoM) values corrected for gestational age (PAPP-A and PlGF) and maternal weight (PAPP-A) were calculated. To obtain prediction models, these biomarkers were included with clinical predictors maternal weight, height, diastolic blood pressure, a previous history of gestational hypertension, history of hypertension in parents and parity in a logistic regression to obtain prediction models. The Area Under the Receiver Operating Characteristic Curve (AUC) was used to assess the predictive ability of the models. RESULTS: Three hundred and seventy three women participated in this study. The area under the curve (AUC) of the model with only maternal clinical characteristics was 0.75 (0.64–0.86) and 0.89(0.73–1.00) for multiparous and primigravid women respectively. The AUCs after inclusion of both PAPP-A and PlGF were 0.82 (0.74–0.89) and 0.95 (0.87–1.00) for multiparous and primigravid women respectively. CONCLUSION: Adding the biomarkers PAPP-A and PlGF to maternal characteristics to a prediction model for gestational hypertension in a cohort of Ghanaian pregnant women improved predictive ability. Further research using larger sample sizes in similar settings to validate these findings is recommended.
format Online
Article
Text
id pubmed-5870183
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58701832018-03-29 Improved prediction of gestational hypertension by inclusion of placental growth factor and pregnancy associated plasma protein-a in a sample of Ghanaian women Antwi, Edward Klipstein-Grobusch, Kerstin Browne, Joyce L. Schielen, Peter C. Koram, Kwadwo A. Agyepong, Irene A. Grobbee, Diederick E. Reprod Health Research BACKGROUND: We assessed whether adding the biomarkers Pregnancy Associated Plasma Protein-A (PAPP-A) and Placental Growth Factor (PlGF) to maternal clinical characteristics improved the prediction of a previously developed model for gestational hypertension in a cohort of Ghanaian pregnant women. METHODS: This study was nested in a prospective cohort of 1010 pregnant women attending antenatal clinics in two public hospitals in Accra, Ghana. Pregnant women who were normotensive, at a gestational age at recruitment of between 8 and 13 weeks and provided a blood sample for biomarker analysis were eligible for inclusion. From serum, biomarkers PAPP-A and PlGF concentrations were measured by the AutoDELFIA immunoassay method and multiple of the median (MoM) values corrected for gestational age (PAPP-A and PlGF) and maternal weight (PAPP-A) were calculated. To obtain prediction models, these biomarkers were included with clinical predictors maternal weight, height, diastolic blood pressure, a previous history of gestational hypertension, history of hypertension in parents and parity in a logistic regression to obtain prediction models. The Area Under the Receiver Operating Characteristic Curve (AUC) was used to assess the predictive ability of the models. RESULTS: Three hundred and seventy three women participated in this study. The area under the curve (AUC) of the model with only maternal clinical characteristics was 0.75 (0.64–0.86) and 0.89(0.73–1.00) for multiparous and primigravid women respectively. The AUCs after inclusion of both PAPP-A and PlGF were 0.82 (0.74–0.89) and 0.95 (0.87–1.00) for multiparous and primigravid women respectively. CONCLUSION: Adding the biomarkers PAPP-A and PlGF to maternal characteristics to a prediction model for gestational hypertension in a cohort of Ghanaian pregnant women improved predictive ability. Further research using larger sample sizes in similar settings to validate these findings is recommended. BioMed Central 2018-03-27 /pmc/articles/PMC5870183/ /pubmed/29587776 http://dx.doi.org/10.1186/s12978-018-0492-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Antwi, Edward
Klipstein-Grobusch, Kerstin
Browne, Joyce L.
Schielen, Peter C.
Koram, Kwadwo A.
Agyepong, Irene A.
Grobbee, Diederick E.
Improved prediction of gestational hypertension by inclusion of placental growth factor and pregnancy associated plasma protein-a in a sample of Ghanaian women
title Improved prediction of gestational hypertension by inclusion of placental growth factor and pregnancy associated plasma protein-a in a sample of Ghanaian women
title_full Improved prediction of gestational hypertension by inclusion of placental growth factor and pregnancy associated plasma protein-a in a sample of Ghanaian women
title_fullStr Improved prediction of gestational hypertension by inclusion of placental growth factor and pregnancy associated plasma protein-a in a sample of Ghanaian women
title_full_unstemmed Improved prediction of gestational hypertension by inclusion of placental growth factor and pregnancy associated plasma protein-a in a sample of Ghanaian women
title_short Improved prediction of gestational hypertension by inclusion of placental growth factor and pregnancy associated plasma protein-a in a sample of Ghanaian women
title_sort improved prediction of gestational hypertension by inclusion of placental growth factor and pregnancy associated plasma protein-a in a sample of ghanaian women
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870183/
https://www.ncbi.nlm.nih.gov/pubmed/29587776
http://dx.doi.org/10.1186/s12978-018-0492-9
work_keys_str_mv AT antwiedward improvedpredictionofgestationalhypertensionbyinclusionofplacentalgrowthfactorandpregnancyassociatedplasmaproteinainasampleofghanaianwomen
AT klipsteingrobuschkerstin improvedpredictionofgestationalhypertensionbyinclusionofplacentalgrowthfactorandpregnancyassociatedplasmaproteinainasampleofghanaianwomen
AT brownejoycel improvedpredictionofgestationalhypertensionbyinclusionofplacentalgrowthfactorandpregnancyassociatedplasmaproteinainasampleofghanaianwomen
AT schielenpeterc improvedpredictionofgestationalhypertensionbyinclusionofplacentalgrowthfactorandpregnancyassociatedplasmaproteinainasampleofghanaianwomen
AT koramkwadwoa improvedpredictionofgestationalhypertensionbyinclusionofplacentalgrowthfactorandpregnancyassociatedplasmaproteinainasampleofghanaianwomen
AT agyepongirenea improvedpredictionofgestationalhypertensionbyinclusionofplacentalgrowthfactorandpregnancyassociatedplasmaproteinainasampleofghanaianwomen
AT grobbeediedericke improvedpredictionofgestationalhypertensionbyinclusionofplacentalgrowthfactorandpregnancyassociatedplasmaproteinainasampleofghanaianwomen